Agios Pharmaceuticals Inc (AGIO)
R&D Expenses
$100.75M
Quarterly · Period ending: · USD
AGIO R&D Expenses
Latest reported$100.75Mperiod ending
Latest reported$100.75Mperiod ending
AGIO Quarterly R&D Expenses ($9.55M → $100.75M)
Quarterly R&D Expenses
High-resolution chart · PNG
AGIO r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 100,754,000 | |
| 79,785,000 | |
| 86,790,000 | |
| 85,422,000 | |
| 90,681,000 | |
| 71,465,000 | |
| 82,810,000 | |
| 72,455,000 | |
| 75,808,000 | |
| 67,272,000 | |
| 76,086,000 | |
| 81,841,000 | |
| 67,087,999 | |
| 65,510,999 | |
| 68,484,000 | |
| 62,985,000 | |
| 72,232,000 | |
| 67,645,000 | |
| 71,097,000 | |
| 61,791,000 | |
| 59,657,000 | |
| 55,188,000 | |
| 95,742,000 | |
| 89,555,000 | |
| 90,917,000 | |
| 91,256,000 | |
| 106,248,000 | |
| 101,672,000 | |
| 107,389,000 | |
| 95,585,000 | |
| 93,809,000 | |
| 82,561,000 | |
| 86,730,000 | |
| 78,224,000 | |
| 77,216,000 | |
| 72,917,000 | |
| 79,816,000 | |
| 62,732,000 | |
| 64,678,000 | |
| 60,643,000 | |
| 50,804,000 | |
| 44,038,000 | |
| 36,933,000 | |
| 36,028,000 | |
| 36,423,000 | |
| 32,443,000 | |
| 34,863,000 | |
| 25,526,000 | |
| 22,576,000 | |
| 17,407,000 | |
| 15,279,000 | |
| 14,803,000 | |
| 12,958,000 | |
| 11,462,000 | |
| 11,225,000 | |
| 9,798,000 | |
| 10,463,000 | |
| 9,551,000 |